EAU NMIBC Risk Calculator 17+

European Association of Urology

專為 iPad 設計

    • 免費

螢幕截圖

描述

This app estimates the probability of a Non–muscle Invasive Bladder Cancer (NMIBC) patient’s progression to MIBC after trans-urethral resection of bladder tumours (TURBT) and calculates their updated European Association of Urology (EAU) Prognostic Factor Risk Group. It Incorporates both the WHO 2004/2016 and WHO 1973 Grading Classification Systems and is based on the following publication:

Sylvester RJ, et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. Eur Urol (2021),https://doi.org/10.1016/j.eururo.2020.12.033

It is a tool that can be used to help inform treatment decisions, but it does not provide professional advice and it can never replace clinical expertise. Treatment decisions for individual patients should take into account not only clinical expertise, but also patient personal values and their preferences.

This calculator has been developed by Ydeal for the EAU. Its developers and its distributors assume no responsibility for the accuracy of the results that are provided or for possible flaws in the system. Nor are they liable for special, direct, indirect or consequential damages, charges, claims, costs, demands, losses, fees or expenses of any nature or kind arising from use of the system.

Comments, suggestions and any errors that are found should be sent to info@nmibc.net

© European Association of Urology

By using the system, the User agrees to these conditions and to abide by international copyright laws and all other applicable laws involving copyright.

App 私隱

開發者表明European Association of Urology的私隱慣例或包括下列資料的處理。詳情請參閱開發者的私隱政策

不收集資料

開發者不會從此 App 收集任何資料。

私隱慣例或因使用的功能或年齡等因素而異。進一步了解

更多此開發者的出品

你可能也喜歡

Cancer Risk
醫藥
GeSRU App
醫藥
Urología Práctica 5ª edición
醫藥
Prostatakarzinom onkowissen
醫藥
Urothelkarzinom onkowissen
醫藥
Nierenzellkarzinom onkowissen
醫藥